𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drug resistance in ovarian cancer — the role of p53

✍ Scribed by Russel Petty; Alan Evans; Iain Duncan; Christian Kurbacher; Ian Cree


Publisher
Springer Netherlands
Year
1998
Tongue
English
Weight
772 KB
Volume
4
Category
Article
ISSN
1219-4956

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Increased accumulation of p53 protein in
✍ Robert Brown; Carol Clugston; Angela Edlin; Paul Vasey; Stanley B. Kaye; Philip 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 942 KB

## Abstract We have examined p53 protein levels in cell lines selected for resistance to the chemotherapeutic drug __cis__‐diamminedichloroplatinum (II), cisplatin. The majority of the independent cisplatin‐resistant clones isolated by a single selection with cisplatin from the ovarian tumour cell

Mechanism of resistance to cisplatin in
✍ Faina Vikhanskaya; Luana Clerico; Monica Valenti; Maria S. Stanzione; Massimo Br 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 99 KB 👁 2 views

A possible novel mechanism of cross-resistance to cisplatin (CDDP) in the doxorubicin-resistant ovarian-cancer cell line A2780-DX3, which displays atypical multidrug resistance, is presented. A2780-DX3 is found to be more resistant than the parental line A2780 in terms of CDDP-induced cytotoxicity a

Akt promotes cisplatin resistance in hum
✍ Michael Fraser; Tao Bai; Benjamin K. Tsang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 736 KB

## Abstract Resistance to cisplatin‐based chemotherapy is a major cause of treatment failure in human ovarian cancer. Wild‐type __TP53__ status is often, but not always, associated with cisplatin sensitivity, suggesting that additional factors may be involved. Overexpression/activation of the phosp